-
CMPX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Compass Therapeutics (CMPX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 36.80 mm | 36.80 mm | 36.80 mm | 36.80 mm | 36.80 mm | 36.80 mm |
Cash burn (monthly) | (no burn) | (no burn) | 4.08 mm | 4.62 mm | 3.68 mm | 4.00 mm |
Cash used (since last report) | n/a | n/a | 16.44 mm | 18.62 mm | 14.85 mm | 16.14 mm |
Cash remaining | n/a | n/a | 20.36 mm | 18.18 mm | 21.96 mm | 20.66 mm |
Runway (months of cash) | n/a | n/a | 5.0 | 3.9 | 6.0 | 5.2 |
13F holders | Current |
---|---|
Total holders | 82 |
Opened positions | 13 |
Closed positions | 15 |
Increased positions | 28 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 168.92 bn |
Total shares | 113.87 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 22.36 mm | $41.15 bn |
Adage Capital Partners GP, L.L.C. | 11.13 mm | $20.48 bn |
BX Blackstone | 10.03 mm | $18.45 bn |
Blackstone Holdings II | 9.50 mm | $9.78 mm |
Commander Aggregator | 7.79 mm | $31.15 mm |
BlackRock | 6.82 mm | $12.55 bn |
MPM Oncology Impact Management | 5.64 mm | $10.38 bn |
Rock Springs Capital Management | 5.63 mm | $10.36 bn |
Foresite Capital Fund V | 4.40 mm | $0.00 |
Vanguard | 4.28 mm | $7.88 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jan 25 | Schuetz Thomas J. | Common Stock | Payment of exercise | Dispose F | No | No | 1.86 | 58,054 | 107.98 k | 6,512,512 |
9 Dec 24 | Shin Barry | Common Stock | Grant | Acquire A | No | No | 1.65 | 400,000 | 660.00 k | 400,000 |
9 Dec 24 | Shin Barry | Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 400,000 | 660.00 k | 400,000 |
13 Aug 24 | Jonathan Anderman | Stock Option CommonStock | Grant | Acquire A | No | No | 1.2 | 300,000 | 360.00 k | 300,000 |